Navigation Links
Bleeding Risk With Plavix-Aspirin Regimen May Be Serious

By Steven Reinberg
HealthDay Reporter

MONDAY, Nov. 22 (HealthDay News) -- Risk of bleeding for patients on antiplatelet therapy with either warfarin or a combination of Plavix (clopidogrel) and aspirin is substantial, a new study finds.

Both therapies are prescribed for millions of Americans to prevent life-threatening blood clots, especially after a heart attack or stroke. But the Plavix-aspirin combination was thought to cause less bleeding than it actually does, the researchers say.

"As with all drugs, these drugs come with risks; the most serious is bleeding," said lead author Dr. Nadine Shehab, from the U.S. Centers for Disease Control and Prevention (CDC).

While the risk of bleeding from warfarin is well-known, the risks associated with dual therapy were not well understood, she noted.

"We found that the risk for hemorrhage was threefold higher for warfarin than for dual antiplatelet therapy," Shehab said. "We expected that because warfarin is prescribed much more frequently than dual antiplatelet therapy."

However, when the researchers took the number of prescriptions into account, the gap between warfarin and dual antiplatelet therapy shrank, Shehab said. "And this was worrisome," she added.

For both regimens, the number of hospital admissions because of bleeding was similar. And bleeding-related visits to emergency department visits were only 50 percent lower for those on dual antiplatelet therapy compared with warfarin, Shehab explained.

"This isn't as big a difference as we had thought," she said.

For the study, published Monday in the Archives of Internal Medicine, Shehab's team used national databases to identify emergency department visits for bleeding caused by either dual antiplatelet therapy or warfarin between 2006 and 2008.

The investigators found 384 annual emergency department visits for bleeding among patients taking dual antiplatelet therapy and 2,926 annual visits for those taking warfarin.

Among those taking Plavix and aspirin, about 60 percent of the visits were for nosebleeds or other minor bleeds. The rate of emergency department visits was 1.2 for every 1,000 prescriptions for dual antiplatelet therapy, compared with 2.5 for every 1,000 prescriptions for warfarin, the researchers found.

"There is an inclination in the clinical community to treat the hemorrhagic risk of dual antiplatelet therapy a little bit less seriously than [the risk for] warfarin," Shehab said. "We hope by shedding some light on the burden and the nature of the bleeding risks of dual antiplatelet therapy that providers will take the risk seriously," she added.

Moreover, doctors should inform their patients of the risks for small bleeds associated with dual antiplatelet therapy, she noted.

Shehab cautioned that this study is not designed to recommend one therapy over another, but only to assess the problem of bleeding for dual antiplatelet therapy.

Dr. Gregg Fonarow, American Heart Association spokesman and professor of cardiology at the University of California, Los Angeles, said that "the use of dual antiplatelet therapy with aspirin and clopidogrel significantly reduces the risk of cardiovascular events in patients after acute coronary syndromes and patients undergoing coronary stenting."

There is a well-defined increased risk of major and minor bleeding with dual antiplatelet therapy, but in most patients the benefits of therapy outweigh these risks, he said.

"These findings reinforce the need for patients receiving dual antiplatelet therapy to be well-educated on the benefits of treatment and the importance of adherence, but also the increased risk of major and minor bleeding," Fonarow said.

More information

For more information on antiplatelet therapy, visit the American Heart Association.

SOURCES: Nadine Shehab, Pharm.D., M.P.H., U.S. Centers for Disease Control and Prevention; Gregg Fonarow, M.D., American Heart Association spokesman, and professor of cardiology, University of California, Los Angeles; Nov. 22, 2010, Archives of Internal Medicine

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Brain bleeding is common with aging, UCI study finds
2. Vitamin E May Pose Slight Bleeding-Stroke Risk
3. Hemostatic powder stops bleeding ulcers: Doctor
4. Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding
5. Adherence to practice guidelines may reduce bleeding in cirrhosis patients
6. Drug That Stops Bleeding Could Save Lives
7. Study finds beta blockers alone more effective for first variceal bleeding
8. Dual Therapy Best for Preventing Bleeding After Heart Procedures
9. First study examines postpolypectomy bleeding in colonoscopy patients on uninterrupted clopidogrel
10. Patients Who Take a Proton-Pump Inhibitor With Medicine to Prevent Blood Clots Are Less Likely to Be Hospitalized for Bleeding Ulcers
11. Bleeding Alert Sounded for Stroke Drugs
Post Your Comments:
Related Image:
 Bleeding Risk With Plavix-Aspirin Regimen May Be Serious
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: